Topics

Enlighten Company Profile

12:11 EST 12th December 2019 | BioPortfolio

Enlighten is a leading technology provider in the cannabis industry, bringing cutting edge retail technology and media solutions to more than 1,200 customers across the U.S. and Canada. One of the longest-tenured and most well-funded companies within cannabis, Enlighten’s multi-faceted ecosystem touches tens of millions of consumers.  With its education-forward approach, Enlighten helps partners grow their brands and build relationships with customers through a variety of solutions that reach the largest possible cannabis-focused audiences as the company serves more than two billion ad impressions per year.   


News Articles [3 Associated News Articles listed on BioPortfolio]

Enlighten Further Solidifies Market Leader Position with Acquisition of Cannabis Club TV

With the acquisition of California based Cannabis Club TV, Enlighten continues its rapid ascent as a premier cannabis media company. Enlighten, a multifaceted cannabis technology company, announced ...

AI Psychiatry?; Schizophrenia Tx Ranked; Omega-3 for ADHD

]]>(MedPage Today) -- Alkermes is seeking FDA approval of olanzapine/samidorphan treatment ALKS 3831 for schizophrenia and bipolar I disorder, based on the ENLIGHTEN clinical program. In other news, ...

Is 'Diabetic' a Dirty Word? A Doctor and Patient Debate

Why do some patients hate being called a diabetic? And why won't some clinicians stop using that word? A patient and doctor come together in an attempt to enlighten and understand each other. Medsca...

Drugs and Medications [0 Results]

None

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Editor's Note: The Beauty and Convenience of Simplicity: Will It Help Enlighten Our Understanding of Progressive Supranuclear Palsy?

The Gut Feeling: GPCRs Enlighten the Way.

Host-microbiome interactions affect host physiology, but the underlying mechanisms are not well understood. Recent papers from Chen et al. (2019) and Colosimo et al. (2019) in this issue of Cell Hos...

Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.

The aim of this study was to enlighten the controversy about the renal safety of entecavir, tenofovir, and telbivudine treatments in chronic hepatitis B (CHB) patients by comparing these treatments in...

Pituitary Adenylate Cyclase-Activating Peptide (PACAP) and its receptors in Mus musculus testis.

To enlighten the involvement of PACAP/receptors system in the control of mammal testis, we investigated the expression of PACAP and the localization of PACAP and its receptors PAC1, VPAC1, and VPAC2 i...

Revisiting mTOR inhibitors as anticancer agents.

The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine kinase that regulates a variety of cellular processes, influencing diverse pathological conditions including a variety o...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment

The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm Nd:YAG picosecond pulse duration laser and an i...

Multi-Wavelength Laser Tattoo Removal Pivotal Study

Mult-center study to evaluate the safety and efficacy of an investigational version of the Cutera enlighten laser that offers multiple wavelengths for tattoo removal

enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars

The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm Nd:YAG picosecond pulse duration laser and an i...

A Prospective Multi-Center Study Using Laser for the Treatment of Melasma and Lentigines in Asian Skin

The purpose of this investigation is to evaluate safety and efficacy of the Cutera enlighten dual-pulse duration, dual-wavelength 532nm KTP/1064nm Nd:YAG laser for the treatment of melasma...

Split-tattoo Study Comparing the Safety and Efficacy of 670nm Picosecond Laser Versus 755 nm for Tattoo Removal

Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser

Companies [1 Associated Companies listed on BioPortfolio]

Enlighten

Enlighten is a leading technology provider in the cannabis industry, bringing cutting edge retail technology and media solutions to more than 1,200 customers across the U.S. and Canada. One of the...

More Information about "Enlighten" on BioPortfolio

We have published hundreds of Enlighten news stories on BioPortfolio along with dozens of Enlighten Clinical Trials and PubMed Articles about Enlighten for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Enlighten Companies in our database. You can also find out about relevant Enlighten Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record